Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson (JNJ) Stock Price & Market Analysis
JNJ · NYSE · Drug Manufacturers - General
$270.47
▲ +$3.33(+1.25%)4:00 PM ET - vs previous closeQuote as of Nov 20, 2026, 4:00 PM EST
Regular-session close · Nov 20, 2026, 4:00 PM EST.
Long-term rangesAvailable historyHide
Historical range: 2000-11-22–2026-11-20. Earlier trading may not be included.
Loading price chart…
Data dates
PriceAt closeLast traded
FundamentalsLast checked
AnalystLast checked
NewsLatest item
What matters next
Next important events
- Jan 26, 2027Next earnings (est.) · After market closeEstimated · After market close · Last verified 2026-11-21
Countdown
65 days out
Reported fundamentals
JNJ financial overview
Annual revenue
USD 94.19B
Sales for the fiscal year ended Dec 28, 2025. This is not trailing twelve-month revenue.
Revenue change
+6.0%
Change versus the fiscal year ended Dec 29, 2024.
Net profit margin
28.5%
Net income divided by revenue for the fiscal year ended Dec 28, 2025. This is not the trailing margin.
These reported results describe the business’s recent scale and profitability. Compare cash generation and valuation before forming an investment view; historical growth is not a forecast.
Company · ProfileAbout Johnson & Johnson (JNJ)Sector, leadership, and how Johnson & Johnson earns its revenue.Healthcare
Johnson & Johnson
NYSE · JNJ · US
Company overview as of Nov 22, 2026.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- New Brunswick, NJ, United States
- Country
- US
- Founded
- 1944
- Employees
- 141,700
- CEO
- Mr. Joaquin Duato
- Exchange
- NYSE
Business model & operating resultsExplore business exposure, reported operating measures and the figures behind growth and profitability claims.
Narrative versus numbers
Demand is expanding
Supporting observation: 5.9%
Year-over-year growth in the latest quarter. This differs from the fiscal-year revenue change shown above. · Source timestamp: Sep 27, 2026
Growth produces accounting profit
Supporting observation: 16.2%
Net margin; the source did not supply a reporting period. Do not compare this reading with the quarterly or fiscal-year figures above. A positive margin does not establish cash generation. · Source timestamp: Nov 22, 2026, 3:12 PM EST
The business generates cash after investment
Supporting observation: USD 6.36B
Latest free cash flow from the statement feed. It is not a forecast and may cover a different period from the fiscal-year figures above. · Source timestamp: Sep 27, 2026
These are explicit tests of individual claims, not an overall bull/bear rating. Demand growth can coexist with valuation, concentration and financing risk.
Operating measures
- Revenue
- $25.40Bquarter ended Sep 27, 2026
- Gross margin
- 68.1%quarter ended Sep 27, 2026
- EPS
- $0.09quarter ended Sep 27, 2026
- Capital expenditure
- $1.36Bquarter ended Sep 27, 2026
- Free cash flow
- $6.36Bquarter ended Sep 27, 2026
- Free cash flow margin
- 25.0%quarter ended Sep 27, 2026
- Operating cash / net income
- 36.76×quarter ended Sep 27, 2026
- Revenue growth year over year
- 5.9%quarter ended Sep 27, 2026
Competitors & comparisonsCompare industry peers, reporting periods and related funds. Business mix and valuation bases may differ.
Valuation & fund comparisonsExplore dated peer valuations, growth comparisons and related funds.
Governance & sustainability
Market closed
Regular hours: 9:30 AM–4:00 PM America/New_York
Next open: 2026-11-23 · 9:30 AM America/New_York
Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.
Shortcuts
With research tools focused: / search · W watchlist · C compare · F financials · E earnings · N news · T technicals · Esc close